Home » Topics » BioWorld Science

BioWorld Science
RSS

Agios Pharmaceuticals and the University of Michigan describe menin/MLL interaction inhibitors

April 29, 2021

Kainos Medicine presents new IRAK-4 inhibitors

April 29, 2021

New Bruton tyrosine kinase inhibitors identified at Newave Pharmaceutical

April 29, 2021

New antiviral compounds discovered at Enanta Pharmaceuticals

April 29, 2021

Bolt Biotherapeutics patents antibody-drug conjugates including TRL7/8 agonists

April 29, 2021

Haihe starts first-in-human study of HH-30134 in advanced solid tumors

April 29, 2021

Amgen initiates phase IIb trial of tezepelumab for chronic spontaneous urticaria

April 29, 2021

Okyo reports preclinical data with OK-201 in mouse neuropathic corneal pain model

April 29, 2021

Enrollment starts in phase II/III study of BI-767551 in mild to moderate COVID-19

April 29, 2021

Hisamitsu reports phase III results with HP-5070 in primary palmar hyperhidrosis

April 28, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...